A new White Paper titled “Pharmacy Benefit Alternative Funding Programs: Key Considerations for Self-Funded Plan Sponsors” details how the saving alleged from alternative funding programs may actually be lower than initially anticipated due to factors such as lost rebate revenue, PAP ineligibility, and increased administrative fees. The White Paper also highlights several potential compliance risks associated with AFPs, including income discrimination, tax implications, HIPAA compliance, and fiduciary responsibilities. Read the white paper here.
Last Updated on July 18, 2024 by Aimed Alliance
